Please ensure Javascript is enabled for purposes of website accessibility

CVS Health Beats Expectations in Q1 Due to COVID-19 Fears

By Keith Speights - May 6, 2020 at 10:59AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Consumers stocking up to prepare for pandemic lockdowns helped boost the healthcare giant's sales.

CVS Health (CVS 1.38%) reported its first-quarter results before the market opened on Wednesday, announcing revenue up 8.3% year over year to $66.8 billion. That well exceeded the average analysts' estimate of $66.04 billion. On the bottom line, the healthcare giant posted GAAP earnings per share (EPS) of $1.53, and adjusted EPS of $1.91, topping the analysts' consensus forecast of $1.63. 

The company reported that revenue for its pharmacy services segment increased by 4.2% year over year in Q1 to nearly $35 billion. Revenue from the company's retail/long-term care segment jumped 7.7% to $22.7 billion. Both segments saw higher sales in part as a result of consumers refilling prescriptions early and more frequently choosing to buy 90-day supplies of drugs in preparation for pandemic-related lockdowns. Its retail business also benefited from increased consumer health and general merchandise sales, which were also driven primarily by the COVID-19 pandemic.

CVS pharmacy store

Image source: CVS Health.

CVS Health's healthcare benefits segment, which includes large health insurer Aetna, generated revenue of $19.2 billion in the first quarter, up 7.4% year over year. This growth was largely fueled by Aetna's government products and a positive impact from the reinstatement of the Affordable Care Act's health insurance fee for 2020. 

While some companies in the healthcare sector have withdrawn all of their 2020 guidance, CVS Health confirmed parts of its previously stated outlook. The company continues to expect full-year GAAP diluted EPS will be between $5.47 and $5.60 with adjusted EPS between $7.04 and $7.17. CVS also projects full-year cash flow will be between $10.5 billion and $11 billion. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$93.94 (1.38%) $1.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.